AQR Capital Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $863K | Buy |
314,866
+24,352
| +8% | +$77.1K | ﹤0.01% | 2852 |
|
|
2025
Q4 | $1.07M | Buy |
290,514
+5,608
| +2% | +$18.1K | ﹤0.01% | 2504 |
|
|
2025
Q3 | $755K | Buy |
284,906
+100,539
| +55% | +$194K | ﹤0.01% | 2593 |
|
|
2025
Q2 | $181K | Buy |
184,367
+122,480
| +198% | +$123K | ﹤0.01% | 3072 |
|
|
2025
Q1 | $89.1K | Sell |
61,887
-136,032
| -69% | -$251K | ﹤0.01% | 3029 |
|
|
2024
Q4 | $435K | Sell |
197,919
-31,411
| -14% | -$73.3K | ﹤0.01% | 2312 |
|
|
2024
Q3 | $378K | Buy |
+229,330
| New | +$463K | ﹤0.01% | 2288 |
|
|
2023
Q4 | – | Sell |
-202,985
| Closed | -$199K | – | 2363 |
|
|
2023
Q3 | $199K | Buy |
+202,985
| New | +$294K | ﹤0.01% | 2145 |
|
|
2022
Q2 | – | Sell |
-41,059
| Closed | -$191K | – | 2210 |
|
|
2022
Q1 | $191K | Buy |
+41,059
| New | +$176K | ﹤0.01% | 2072 |
|
|
2020
Q2 | – | Sell |
-10,774
| Closed | -$340K | – | 2117 |
|
|
2020
Q1 | $340K | Buy |
+10,774
| New | +$569K | ﹤0.01% | 1726 |
|
|
2019
Q4 | – | Sell |
-6,216
| Closed | -$228K | – | 2135 |
|
|
2019
Q3 | $228K | Buy |
+6,216
| New | +$246K | ﹤0.01% | 1978 |
|
|
2018
Q3 | – | Sell |
-11,442
| Closed | -$448K | – | 2281 |
|
|
2018
Q2 | $448K | Sell |
11,442
-51,894
| -82% | -$2.62M | ﹤0.01% | 2013 |
|
|
2018
Q1 | $4.58M | Buy |
63,336
+37,956
| +150% | +$2.79M | ﹤0.01% | 1035 |
|
|
2017
Q4 | $1.67M | Sell |
25,380
-78,346
| -76% | -$4.22M | ﹤0.01% | 1452 |
|
|
2017
Q3 | $5.2M | Buy |
103,726
+74,319
| +253% | +$3.58M | 0.01% | 1005 |
|
|
2017
Q2 | $1.36M | Buy |
+29,407
| New | +$1.08M | ﹤0.01% | 1552 |
|
|
2015
Q4 | – | Sell |
-60,167
| Closed | -$1.42M | – | 2254 |
|
|
2015
Q3 | $1.42M | Sell |
60,167
-16,129
| -21% | -$1.01M | ﹤0.01% | 1276 |
|
|
2015
Q2 | $6.24M | Buy |
76,296
+8,296
| +12% | +$812K | 0.01% | 753 |
|
|
2015
Q1 | $6.3M | Buy |
68,000
+55,900
| +462% | +$3.61M | 0.01% | 701 |
|
|
2014
Q4 | $489K | Buy |
+12,100
| New | +$370K | ﹤0.01% | 1975 |
|
Other funds holding ESPR
WA
TSC
O
VCM
